Published • loading... • Updated
Nvidia, QIA-backed Iambic Therapeutics files for US IPO as biotech boom rolls on
The AI drug developer is targeting a Nasdaq listing as biotech IPOs stay resilient and major drugmaker acquisitions support sector fundraising.
Summary by Channel News Asia
7 Articles
7 Articles
Channel News Asia+2 Reposted by 2 other sources
Nvidia, QIA-backed Iambic Therapeutics files for US IPO as biotech boom rolls on
Sept 21 : Drug developer Iambic Therapeutics, backed by chip giant Nvidia and Qatar's sovereign wealth fund, filed for a US initial public offering on Monday, bolstering a busy slate of biotech listings in the fall window.While the fall IPO window has gotten off to a rocky start amid uncertainty surrounding t
·Singapore, Singapore
Read Full Article
Crypto BriefingReposted by 
Cryptocurrency News | Cryptocurrency Prices | Market Cap
Cryptocurrency News | Cryptocurrency Prices | Market CapIambic Therapeutics files for US IPO with Nvidia backing
Iambic Therapeutics filed an S-1 for a Nasdaq IPO under ticker IAM, backed by Nvidia and other major investors after raising $461.8 million since
Coverage Details
Total News Sources7
Leaning Left0Leaning Right0Center3Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
